King Faisal University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Al-Ahsa Saudi Arabia (1975)

Organization Overview

First Clinical Trial
2001
NCT00531583
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

King Faisal Specialist Hospital and Research cente | King Faisal Specialist Hospital and research Centre | King Faisal Specialist Hospital & Research Cener -Jeddah | King Faisal Specialist Hospital & Research Center | King Faisal Specialist Hospital & Research Centre | King Faisal Specialist Hospital & Research Centre, Jeddah | King Faisal Specialist Hospital & Research Centre, Riyadh | King Faisal University

Active Ingredients

Drugs in Phase 4 Trials (8)

basiliximab (Simulect) (1 trial)

elbasvir (1 trial)

ergocalciferol (drisdol) (3 trials)

grazoprevir (zepatier) (1 trial)

insulin glargine (toujeo) (1 trial)

insulin human (humulin) (1 trial)

somatostatin (1 trial)

vitamin d3 (5 trials)

Drugs in Phase 3 Trials (20)

avibactam (Avycaz) (1 trial)

bortezomib (velcade) (1 trial)

capecitabine (xeloda) (2 trials)

ceftazidime (fortaz) (1 trial)

cisplatin (platinol) (6 trials)

colistin (1 trial)

cyclophosphamide (cytoxan) (4 trials)

dexmedetomidine (precedex) (2 trials)

docetaxel (taxotere) (5 trials)

fluorouracil (efudex) (4 trials)

gemcitabine (gemzar) (2 trials)

goserelin (zoladex) (1 trial)

ketamine (ketalar) (1 trial)

lenalidomide (revlimid) (1 trial)

leucovorin (2 trials)

methotrexate (1 trial)

midazolam (versed) (1 trial)

oxaliplatin (eloxatin) (2 trials)

temozolomide (temodar) (1 trial)

urea (1 trial)

Drugs in Phase 2 Trials (16)

aminophylline (aminophyllin) (1 trial)

Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)

bevacizumab (avastin) (2 trials)

doxapram (dopram) (1 trial)

durvalumab (imfinzi) (1 trial)

ephedrine (1 trial)

everolimus (zortress) (1 trial)

folfirinox (1 trial)

irinotecan (Camptosar) (2 trials)

ketoglutarate (1 trial)

l-histidine (1 trial)

paclitaxel (taxol) (4 trials)

phenylephrine (Prefrin) (1 trial)

stem cells (1 trial)

sunitinib (sutent) (2 trials)

tryptophan (1 trial)

Drugs in Phase 1 Trials (1)

mycophenolate (CellCept) (1 trial)

Drugs in Other Trials (24)

acetaminophen (tylenol) (1 trial)

bacille calmette-guerin (1 trial)

caffeine (2 trials)

carboplatin (paraplatin) (2 trials)

cephalexin (keflex) (1 trial)

dactinomycin (cosmegen) (1 trial)

doxorubicin (Doxil) (3 trials)

doxycycline (vibramycin) (1 trial)

epirubicin (ellence) (1 trial)

esomeprazole (nexium) (1 trial)

glycerin (1 trial)

hydroxyzine (vistaril) (1 trial)

ibuprofen (motrin) (1 trial)

ifosfamide (ifex) (1 trial)

imatinib (gleevec) (1 trial)

insulin degludec (tresiba) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

levofloxacin (levaquin) (1 trial)

peripheral blood lymphocytes (1 trial)

sodium bicarbonate (1 trial)

sodium chloride (1 trial)

tamoxifen (nolvadex) (1 trial)

trastuzumab (herceptin) (1 trial)

vincristine (oncovin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Disease (Phase 3)

Adenocarcinoma (Phase 2)

Anemia (Phase 2)

Anemia, Aplastic (Phase 2)

Biliary Tract Neoplasms (Phase 2)

Breast Neoplasms (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Renal Cell (Phase 2)

Critical Illness (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

End Stage Liver Disease (Phase 4)

Esophageal Neoplasms (Phase 2)

Gastrointestinal Neoplasms (Phase 4)

Glioblastoma (Phase 3)

Heart Diseases (Phase 2)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Hypertension, Portal (Phase 4)

Hypotension (Phase 2)

Leukemia (Phase 3)

Liver Diseases (Phase 4)

Multiple Myeloma (Phase 3)

Nasopharyngeal Carcinoma (Phase 2)

Nasopharyngeal Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 3)

Neuroendocrine Tumors (Phase 2)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Postoperative Complications (Phase 3)

Rectal Neoplasms (Phase 3)

Salivary Gland Neoplasms (Phase 2)

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 55
  • # of Trial APIs: 69